Office of the Director; Notice of Closed Meeting, 55631 [2024-14698]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 129 / Friday, July 5, 2024 / Notices
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; CTSA Collaborative and
Innovative Acceleration Award (CCIA)
Review.
Date: September 11, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 9609 Medical Center Drive,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Jing Chen, Ph.D., Scientific
Review Officer, Office of Scientific Review,
National Center for Advancing Translational
Sciences, National Institutes of Health, 9609
Medical Center Drive, Rockville, MD 20892,
(301) 827–3268, chenjing@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
ddrumheller on DSK120RN23PROD with NOTICES1
BILLING CODE 4140–01–P
Agency Information Collection
Activities: Proposed Collection;
Comment Request
BILLING CODE 4140–01–P
Name of Committee: Office of Research
Infrastructure Programs Special Emphasis
Panel (ZOD1), STOD: Biomedical Research
Facilities.
Date: July 25, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Center
for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Jkt 262001
[FR Doc. 2024–14698 Filed 7–3–24; 8:45 am]
Substance Abuse and Mental Health
Services Administration
[FR Doc. 2024–14700 Filed 7–3–24; 8:45 am]
17:16 Jul 03, 2024
Dated: June 28, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 28, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
VerDate Sep<11>2014
Contact Person: Jonathan Ivins, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, Rockledge II,
6701 Rockledge Drive, MSC 7806, Bethesda,
MD 20892, (301) 594–1245, ivinsj@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS).
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning the
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at (240) 276–
0361.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Minority AIDS
Initiative: Substance Use Disorder
Prevention and Treatment Pilot Program
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
55631
(MAI PT Pilot) Data Collection
Instruments.
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Substance Abuse
Prevention (CSAP) and Center for
Substance Abuse Treatment (CSAT) are
requesting approval from the Office of
Management and Budget (OMB) to
monitor the Minority AIDS Initiative:
Substance Use Disorder Prevention and
Treatment Pilot Program (MAI PT Pilot)
through administration of a suite of data
collection instruments for grant
compliance and programmatic
performance monitoring. This package
describes the data collection activities
and proposed instruments. Two
instruments will facilitate grant
compliance monitoring, and the third
instrument is designed for program
performance monitoring.
• The MAI PT Pilot—Organizational
Readiness Assessment (MAI–ORA) is a
one-time self-assessment tool intended
to guide MAI PT Pilot grant recipients
to objectively assess their capacity to
provide substance use prevention,
substance use disorder or co-occurring
mental health disorder treatment, and
HIV, viral hepatitis, and sexually
transmitted infection prevention,
screening, testing, and referral services
for racial and ethnic individuals
vulnerable to these conditions. Results
from the MAI–ORA will allow
SAMHSA to determine grantee
readiness and capacity to implement
their grant program, so that SAMHSA
can provide additional support, as
needed, to ensure grant compliance.
• The MAI PT Pilot—Programmatic
Progress Report (MAI–PPR) is a template
that grantees will use to report annual
progress and will be used to monitor
grant compliance.
• The MAI PT Pilot—Online
Reporting Tool (MAI–PORT) will be
used to conduct programmatic
performance monitoring. The MAI–
PORT is comprised of two main
sections: (1) Annual Targets Report
section for MAI PT Pilot grant recipients
to report annual federal fiscal year
programmatic goals, and (2) Quarterly
Performance Report for grantees to
report grant activities implemented
during each federal fiscal quarter. In
developing the MAI–PORT Annual
Targets Report and the Quarterly
Performance Report, CSAP/CSAT
sought the ability to elicit programmatic
information that demonstrates impact at
the program aggregate level.
Data collected through the MAI–
PORT are necessary to ensure SAMHSA
and grantees comply with requirements
under the Government Performance and
Results Act Modernization Act of 2010
E:\FR\FM\05JYN1.SGM
05JYN1
]]>Agencies
[Federal Register Volume 89, Number 129 (Friday, July 5, 2024)]
[Notices]
[Page 55631]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-14698]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Office of Research Infrastructure Programs
Special Emphasis Panel (ZOD1), STOD: Biomedical Research Facilities.
Date: July 25, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan Ivins, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health,
Rockledge II, 6701 Rockledge Drive, MSC 7806, Bethesda, MD 20892,
(301) 594-1245, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS).
Dated: June 28, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-14698 Filed 7-3-24; 8:45 am]
BILLING CODE 4140-01-P
